Explore Suprelorin® as a GnRH agonist implant, covering its pharmacological mechanism, approved clinical indications for male dogs and cats, and current scientific evidence supporting its use in veterinary reproductive medicine. This presentation features clinical case analysis to evaluate practical benefits and limitations in real-world settings, helping participants develop evidence-based decision-making skills for incorporating Suprelorin® into routine veterinary practice with guidance from Dr. Lluis Ferré-Dolcet, Dipl. ECAR; PhD; MSc; DVM, a European College of Animal Reproduction diplomate specializing in reproductive endocrinology and GnRH research.